Sysmex (OTCMKTS:SSMXY) Announces FY 2026 Earnings Guidance

Sysmex (OTCMKTS:SSMXY) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 0.415-0.415 for the period, compared to the consensus estimate of 0.440. The company issued revenue guidance of $3.5 billion, compared to the consensus revenue estimate of $3.1 billion.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Sysmex from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 18th. Two equities research analysts have rated the stock with a Hold rating. According to MarketBeat, the company presently has an average rating of “Hold”.

Sysmex Trading Up 3.4%

Shares of SSMXY stock opened at $13.55 on Tuesday. Sysmex has a fifty-two week low of $8.01 and a fifty-two week high of $13.56. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.53 and a current ratio of 3.40. The stock’s fifty day moving average is $12.01 and its two-hundred day moving average is $10.03. The firm has a market capitalization of $8.24 billion, a P/E ratio of 32.26 and a beta of 1.20.

Sysmex (OTCMKTS:SSMXY) last released its earnings results on Tuesday, November 10th. The company reported $0.10 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.10. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. Sysmex has set its FY 2026 guidance at 0.415-0.415 EPS. Research analysts expect that Sysmex will post 0.41 earnings per share for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis.

The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.